Reunion Neuroscience Correlations
| REUNDelisted Stock | USD 1.12 0.01 0.90% |
The current 90-days correlation between Reunion Neuroscience and Braxia Scientific Corp is -0.07 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Reunion Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Reunion Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Reunion Neuroscience Correlation With Market
Good diversification
The correlation between Reunion Neuroscience and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Reunion Neuroscience and DJI in the same portfolio, assuming nothing else is changed.
Reunion |
Moving together with Reunion Stock
| 0.62 | SLF | Sun Life Financial | PairCorr |
| 0.8 | HNRC | Houston Natural Resources | PairCorr |
| 0.79 | AVTE | Aerovate Therapeutics | PairCorr |
| 0.77 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.67 | GOOG | Alphabet Class C Aggressive Push | PairCorr |
| 0.62 | PYPL | PayPal Holdings Aggressive Push | PairCorr |
| 0.78 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.7 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.77 | T | ATT Inc Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.63 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.66 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.7 | DIS | Walt Disney | PairCorr |
| 0.72 | CSCO | Cisco Systems | PairCorr |
| 0.71 | WMT | Walmart | PairCorr |
Moving against Reunion Stock
| 0.86 | CSLLY | CSL | PairCorr |
| 0.83 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.82 | CMXHF | CSL Limited | PairCorr |
| 0.71 | QSAM | Qsam Biosciences | PairCorr |
| 0.7 | NVO | Novo Nordisk AS | PairCorr |
| 0.68 | NONOF | Novo Nordisk AS | PairCorr |
| 0.64 | NIHK | Video River Networks | PairCorr |
| 0.61 | MCAE | Mountain Crest Acqui | PairCorr |
| 0.46 | GLUC | Glucose Health | PairCorr |
| 0.34 | MCAEU | Mountain Crest Acqui | PairCorr |
| 0.89 | KO | Coca Cola Fiscal Year End 11th of February 2025 | PairCorr |
| 0.81 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.8 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.62 | MCD | McDonalds Sell-off Trend | PairCorr |
| 0.57 | VZ | Verizon Communications Fiscal Year End 28th of January 2025 | PairCorr |
| 0.57 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Reunion Stock performing well and Reunion Neuroscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Reunion Neuroscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BRAXF | 13.93 | 2.59 | 0.08 | (0.71) | 13.14 | 50.00 | 133.33 | |||
| ONTTF | 4.10 | 0.17 | 0.03 | 0.26 | 4.08 | 12.03 | 25.17 | |||
| AGNPF | 7.22 | (0.32) | 0.00 | 3.91 | 0.00 | 16.58 | 55.53 | |||
| AWKNF | 7.12 | 0.20 | 0.00 | 0.01 | 0.00 | 18.00 | 43.08 | |||
| ACUT | 7.15 | (0.66) | 0.00 | (0.05) | 0.00 | 20.00 | 56.07 | |||
| NUVL | 2.17 | (0.01) | 0.03 | 0.09 | 2.80 | 3.84 | 36.85 | |||
| OKYO | 2.51 | 0.18 | 0.01 | (0.16) | 3.12 | 4.46 | 29.99 | |||
| OCTHF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| NTII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| PHGUF | 0.44 | 0.02 | 0.00 | (0.11) | 0.00 | 0.00 | 21.69 |
View Reunion Neuroscience Related Equities
| Risk & Return | Correlation |
Reunion Neuroscience Corporate Management
| MD MBA | VP Director | Profile | |
| Nathan BSc | Chief Officer | Profile | |
| Stephan Cote | Head Quality | Profile | |
| Hannan Fleiman | CoFounder Director | Profile | |
| Mujeeb Jafferi | COFounder COO | Profile | |
| Edward CPA | Chief Officer | Profile | |
| Vicki Reed | Chief Officer | Profile |
Still Interested in Reunion Neuroscience?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.